Tarcine BioMed has awarded a patent certificate on Rta/IgG of EB virus CLIA reagent and its application from China Intellectual Property Bureau. This new invented product can detect the Rta/IgG of EB virus in the specimen fast, accurately, sensitively and specifically. Moreover multi-specimens can be tested simultaneously, so the processing time can be reduced for enhancing the effectiveness. Rta/IgG CLIA is valuable on the auxiliary diagnostic and related clinical application on NPC. Its application and the potential market is remarkable.